Director's Note This issue of CCR Milestones highlights some of our scientific advances in FY 2020-2021. Read More
Unlocking Cancer Protein Interactions Within families of Ras/Raf proteins, individual preferences matter. Read More
Once Infamous, Now Beneficial A variation of a once-banned drug proves effective for patients living with AIDS-related Kaposi sarcoma. Read More
Switching on RNA Learning how to design RNA-targeted therapeutics by manipulating a bacterial gene regulator. Read More
Getting It Just Right An adjusted chemotherapy regimen provides a less toxic treatment option for adults with Burkitt lymphoma. Read More
Repeated Mistakes, Shattered Chromosomes Long, repetitive sequences distort DNA and create a unique vulnerability in cancer cells. Read More
Better Together to Diagnose Prostate Cancer A combined biopsy method leads to more accurate prostate cancer diagnoses. Read More
Narrowing Lung Cancer Disparities Deficiencies in DNA repair may lead to higher cancer rates in African Americans diagnosed with a type of lung cancer. Read More
Reprogrammed to Kill Turning tumor-protecting immune cells into killer cells can strengthen the body’s fight against cancer. Read More
Following Viral Footprints A new blood test measures lifetime virus exposure to help predict risk of developing liver cancer. Read More
A First for Kids with NF1 A new drug shrinks tumors and improves quality of life in children. Read More
New Faculty New faculty join CCR each year to contribute to our work of making breakthrough scientific discoveries to find cures and treatments for cancer. Read More
Awards & Honors We are proud of our CCR awardees who represent a spectacular array of accomplishments. Read More
By the Numbers Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR. Read More